Galavit

from Wikipedia, the free encyclopedia
Galavit

Galavit ( Russian галавит ) is the trade name of a drug from the Russian pharmaceutical company Medicor, which is approved in Russia for the immunomodulatory treatment of a variety of inflammatory and infectious diseases of the gastrointestinal tract , the respiratory tract and other organs, as well as secondary conditions after surgery. In Germany, however, Galavit is not approved. The drug hit the headlines in Germany at the beginning of the 2000s because of its extremely dubious use in the treatment of cancer .

Composition and dosage form

The active ingredient of Galavit is given by the manufacturer Aminodihydrophthalazin sodium salt dihydrate (sodium 2-amino-1,4-dioxo-1,2,3,4-tetrahydrophthalazin-3-id-2 water). The substance is structurally related to luminol . The medicine is available as suppositories, sublingual tablets and powder to be made up into a solution for injection.

Effectiveness and harmlessness

The active ingredient is said to have a stimulating effect on the immune system . Galavit was used intravenously in Germany and Switzerland for the alternative medical treatment of cancer. There is no independent proof of efficacy in cancer, and little is known about the pharmacological properties, particularly with regard to safety. Nevertheless, Galavit was occasionally touted and offered as a “miracle cure” for the seriously ill. Galavit is not approved as a medicinal product in the countries of the European Union. The Federal Institute for Drugs and Medical Devices warned against its use in 2001. The Medicines Commission of the German Medical Association and the German Cancer Society also expressly advised against the use of Galavit , and the Swiss study group for complementary and alternative methods in cancer was critical.

Criminal prosecution

A group of dealers who had sold the preparation to cancer patients at much overpriced prices was indicted in the Kassel district court in 2007. The criminally convicted mastermind and now legally convicted businessman Falko Dahms had through the doctor Dr. med. Eike Rauchfuß Galavit in a private clinic in Bad Karlshafen to administer to the largely deceased patients. The three main participants were sentenced on July 15, 2008 by the Kassel district court to up to seven years in prison. Some of the treatments took place in the practice of the controversial physician Nikolaus Klehr , who was also sentenced to a fine for attempting to import Galavit (Landgericht München, Az. 7 NS 66 Js 20973/00).

Individual evidence

  1. a b Galavit im Vidal ( Memento of the original from May 5, 2010 in the Internet Archive ) Info: The archive link was inserted automatically and has not yet been checked. Please check the original and archive link according to the instructions and then remove this notice. (Russian)  @1@ 2Template: Webachiv / IABot / www.vidal.ru
  2. Pharmaceutical Substance List
  3. a b Swiss study group for complementary and alternative methods in cancer: Galavit «Cancer immunotherapy». Documentation No. 06/07 (PDF; 374 kB), Swiss Cancer League, 2006.
  4. BfArM warns of Galavit and Ukrain ( Memento of March 16, 2010 in the Internet Archive ), August 23, 2001 (no longer in the network)
  5. Medicines Commission of the German Medical Association: On the use of the preparation "Galavit" in cancer therapy. In: Dtsch Arztebl. 98 (15), 2001, pp. A-1016 / B-864 / C-812
  6. K. Zinkant: Bad game with the doomed. on: ZEIT online. July 15, 2008.
  7. ^ Prison for Galavit Fraudsters. In: Mercury. September 2, 2009.

Web links